METHODS AND COMPOSITIONS FOR GENERATING TYPE 1 VESTIBULAR HAIR CELLS

NOVEL PRECURSOR MIRNA AND APPLICATION THEREOF IN TUMOR TREATMENT

INHIBITION OF DENND5B EXPRESSION FOR TREATING HEPATIC STEATOSIS

COMBINATION IMMUNOTHERAPIES FOR TREATMENT OF CANCER

COMPOSITIONS AND METHODS OF TREATMENT FOR LYTIC AND LYSOGENIC VIRUSES

APOE GENE THERAPY

METHODS AND COMPOSITIONS FOR TREATING ATHEROSCLEROSIS

MICRO-RNA PROFILING, COMPOSITIONS, AND METHODS OF TREATING DISEASES

MicroRNA (miRNA) and Downstream Targets for Diagnostic and Therapeutic Purposes

ENGINEERED MICROBIAL POPULATION

AN UBIQUITIN LIGASE INHIBITOR FOR USE FOR PREVENTING AND/OR TREATING A DISEASE LINKED WITH CEREBRAL HYPOPERFUSION

Signal-sensor polynucleotides for the alteration of cellular phenotypes

Adeno-Associated Virus Vector Delivery of Microrna-29 to Treat Muscular Dystrophy

NUCLEIC ACID MOLECULES CONTAINING SPACERS AND METHODS OF USE THEREOF

METHODS AND COMPOSITIONS FOR REPROGRAMMING CELLS

ENGINEERED CIRCULAR RNA CIRCMIR-29B AND USE THEREOF IN PREPARATION OF MEDICINE FOR TREATING MUSCLE ATROPHY

Method for Treatment of Alzheimer's Disease

NOVEL MRNA COMPOSITION AND PRODUCTION METHOD FOR USE IN ANTI-VIRAL AND ANTI-CANCER VACCINES

Novel RNA Composition and Production Method for Use in iPS Cell Generation

TRANSKINGDOM PLATFORM FOR THERAPEUTIC NUCLEIC ACID DELIVERY

ADOPTIVE CELL THERAPY USING SPHERICAL NUCLEIC ACIDS (SNAS)

METHOD FOR REDUCING THE EXPRESSION OF NKCC1 IN A SUBJECT

DUAL VIRUSES AND DUAL ONCOLYTIC VIRUSES AND METHODS OF TREATMENT

FLUID DELIVERY SYSTEMS AND METHODS OF TREATMENT

GENE THERAPY TARGETING COCHLEAR CELLS

Modified ribonucleic acids and uses thereof

MICRORNAS ENRICHED IN MEGAKARYOCYTIC EXTRACELLULAR VESICLES AND USES THEREOF

SYSTEMS AND METHODS FOR IN-VITRO MODELING OF NEURODEGENERATIVE DISEASES

COMPOSITIONS AND METHODS FOR REPROGRAMMING AGE-RESTRICTED NON-NEURONAL CELLS

Promotion of Cardiomyocyte Proliferation and Regenerative Treatment of the Heart by Inhibition of microRNA-128

ANELLOVIRUS COMPOSITIONS AND METHODS OF USE

CHIMERIC COMPLEX AND THERAPEUTIC USES THEREOF

CAR NKTs Expressing Artificial Micro RNA-Embedded shRNA for Downregulation of MHC Class I & II Expression

PHARMACEUTICAL COMPOSITION CONTAINING HERES EXPRESSION INHIBITOR FOR PREVENTING OR TREATING SQUAMOUS CELL CARCINOMA

PHARMACEUTICAL COMPOSITIONS, KITS AND METHODS FOR TREATING TUMORS

ANTI-MIRNAS FOR THE TREATMENT OF LEIOMYOMA

GENE VECTOR

Tumor-Targeting Polypeptide Nanoparticle Delivery System for Nucleic Acid Therapeutics

PROCESS OF DELIVERING SMALL RNAS TO SPERM

MULTI-INPUT MIRNA SENSING WITH CONSTITUTIVE ERNS TO REGULATE MULTI-OUTPUT GENE EXPRESSION IN MAMMALIAN CELLS

COMPOSITIONS AND METHODS FOR RNA INTERFERENCE

DIAGNOSTIC AND THERAPEUTIC USES OF COMPOSITIONS COMPRISING PURIFIED, ENRICHED POTENT EXOSOMES CONTAINING DISEASE-BASED AND THERAPY BASED SIGNATURE CARGO

HUMAN HEAD AND NECK CANCER TREATMENT

miRNAS FOR REDUCING VENTRICLE ENLARGEMENT

COMPOSITIONS AND METHODS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS

Methods to detect motor neuron disease comprising micro-RNAs

METHODS AND COMPOSITIONS USING AUXOTROPHIC REGULATABLE CELLS

Use of Thermostable RNA Polymerases to Produce RNAs Having Reduced Immunogenicity

GENERATION OF NEURONS BY REPROGRAMMING OF OLIGODENDROCYTES AND OLIGODENDROCYTE PRECURSOR CELLS

COMBINED TRANSGENE AND INTRON-DERIVED MIRNA THERAPY FOR TREATMENT OF SCA1

COMPOSITIONS AND METHODS FOR DETECTING AND TREATING INSULIN RESISTANCE

USE OF RAB7 GTPASE (RAB7) INHIBITORS IN ENHANCING PERMEABILITY OF THE BLOOD BRAIN BARRIER (BBB)

NEW TREATMENTS INVOLVING MIRNA-193A

ENHANCED TRANSDUCTION OF AAV VECTORS ENCODING MICRORNAS

COMPOSITIONS AND METHODS FOR DECREASING INTRAOCULAR PRESSURE

NUCLEIC ACID DRUG TARGETING MURF1

METHODS FOR TREATING RAN PROTEIN-ASSOCIATED NEUROLOGICAL DISEASES

RNA INTERFERENCE-INDUCING NUCLEIC ACID INHIBITING NONCANONICAL TARGETS OF MICRO RNA, AND USE FOR SAME

COMPOSITIONS AND METHODS FOR DELIVERY OF AGENTS

Micro-RNAs and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions

Inhibitors of microRNA 451a for Treatment of Endometriosis

Compositions and methods for disrupting the molecular mechanisms associated with mitochondrial dysfunction and neurodegenerative disease

Regenerative Therapy Based on miRNA-302 Mimics for Enhancing Host Recovery from Pneumonia Caused by Streptococcus pneumoniae

GENE THERAPY FOR RETINAL DISEASE

NANOVESICLES AND ITS USE FOR NUCLEIC ACID DELIVERY

Compositions and Methods for Monitoring, Diagnosis, Detection and Treatment of Cancer

APTAMERS AGAINST GLIOBLASTOMA

Conjugation of lipophilic albumin-binding moiety to RNA for improved carrier-free in vivo pharmacokinetics and gene silencing

Compositions and methods for monitoring, diagnosis, prognosis, detection, and treatment of cancer

Use of novel miRNA-binding site cassettes for antigen-presenting cell detargeting of transgene expression by rAAV gene therapy vectors

NUCLEIC ACID CARRIER AND METHOD FOR ADMINISTERING NUCLEIC ACID

METHODS AND COMPOSITIONS FOR TREATING PULMONARY ARTERIAL HYPTERNSION

MICRORNAS FOR CARDIAC REGENERATION THROUGH INDUCTION OF CARDIAC MYOCYTE PROLIFERATION

Insulin gene therapy

METHODS AND COMPOSITIONS FOR MODULATION OF AN INTERSPECIES GUT BACTERIAL PATHWAY FOR LEVODOPA METABOLISM

Compositions and processes for targeted delivery, expression and modulation of coding ribonucleic acids in tissue

SYNTHETIC PRODUCTION OF SINGLE-STRANDED ADENO ASSOCIATED VIRAL DNA VECTORS

METHOD FOR CONTROLLING MICRORNA EXPRESSION

Therapeutic pharmaceutical composition for cancer including miRNA

VIRAL VECTORS AND NUCLEIC ACIDS FOR USE IN THE TREATMENT OF PF-ILD AND IPF

Targeted inhibition using engineered oligonucleotides

Targeted inhibition using engineered oligonucleotides

Therapeutic Targeting of a microRNA to Treat Duchenne Muscular Dystrophy

RAAV-based compositions and methods

METHODS FOR EXTRACTING BIOACTIVE SMALL RNAS FROM PLANTS AND MUSHROOMS

Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)

COMPOSITIONS USEFUL IN TREATMENT OF RETT SYNDROME

CELLS WITH MULTIPLEXED INHIBITORY RNA

Therapeutic pharmaceutical composition for cancer including miRNA

RETROVIRAL VECTOR HAVING IMMUNE-STIMULATING ACTIVITY

VIRAL VECTORS FOR THE TREATMENT OF DIABETES

SYNTHETIC MICRORNA MIMICS

Use of miR-18b for prevention, treatment, or diagnosis of muscle disease and neuromuscular disease

MODIFYING THE SPECIFICITY OF NON-CODING RNA MOLECULES FOR SILENCING GENES IN EUKARYOTIC CELLS

Gene therapeutics for fibrodysplasia ossificans progressiva

MicroRNA-198 as a tumor suppressor in ovarian cancer

ENDOSOMAL CLEAVABLE LINKERS

Multicistronic miRNA delivery for cardiac reprogramming

Method for diagnosis of Alzheimer's disease using microrna

NANOSYSTEM BASED ON MICRORNA FOR TREATING OBSESITY

Method for constructing functional exosomes capable of efficiently loading specific miRNA

NOVEL METHOD FOR MONITORING ENDOMETRIOSIS AND ASSOCIATED DISORDERS

Modulatory polynucleotides

Method for stimulating axonal regeneration

BIFUNCTIONAL VECTORS ALLOWING BCL11A SILENCING AND EXPRESSION OF AN ANTI-SICKLING HBB AND USES THEREOF FOR GENE THERAPY OF B-HEMOGLOBINOPATHIES

INTRODUCING SILENCING ACTIVITY TO DYSFUNCTIONAL RNA MOLECULES AND MODIFYING THEIR SPECIFICITY AGAINST A GENE OF INTEREST

BIOMARKERS, AND USES IN TREATMENT OF VIRAL INFECTIONS, INFLAMMATIONS, OR CANCER

TRANSGENIC PLANTS WITH ENHANCED TRAITS

SUPPRESSION OF TARGET GENE EXPRESSION THROUGH GENOME EDITING OF NATIVE MIRNAS

IMMUNOSTIMULATORY BACTERIA ENGINEERED TO COLONIZE TUMORS, TUMOR-RESIDENT IMMUNE CELLS, AND THE TUMOR MICROENVIRONMENT

Anti-miRNA carrier conjugated with a peptide binding to a cancer cell surface protein and use thereof

INHIBITION OF LET7I AS A MEANS TO ENHANCE THE PROTECTIVE EFFECT OF PROGESTERONE AGAINST STROKE

A MEMBRANE-BOUND FIT-1 DECOY AND USES THEREOF

COMPOSITIONS AND METHODS FOR TREATING NEUROCOGNITIVE DISORDERS

MODULATION OF MICRORNAS AGAINST MYOTONIC DYSTROPHY TYPE 1 AND ANTAGONISTS OF MICRORNAS THEREFOR

Methods for Treatment of Alport Syndrome

ARTIFICIAL MICRORNA PRECURSOR AND IMPROVED MICRORNA EXPRESSION VECTOR CONTAINING THE SAME

Modulatory polynucleotides

Methods of modulating RNA translation

Composition, kit, and method for diagnosis and treatment of taxane anticancer agent-resistant cancer

Polycomb-associated Non-Coding RNAs

EXOSOMES AND MICRO-RIBONUCLEIC ACIDS FOR TISSUE REGENERATION

MICRO RNA INTERACTIONS AS THERAPEUTIC TARGETS FOR COVID-19 AND OTHER VIRAL INFECTIONS

Modifications of mammalian cells using artificial micro-RNA to alter their properties and the compositions of their products

COMPOSITIONS COMPRISING SYNTHETIC POLYNUCLEOTIDES ENCODING CRISPR RELATED PROTEINS AND SYNTHETIC SGRNAs AND METHODS OF USE

METHOD FOR TREATING DISEASE USING FOXP3+CD4+ T CELLS

DOUBLE STRANDED RNA AND USES THEREOF

METHODS FOR CONTROLLING SEIZURES BY MANIPULATING THE LEVELS OF MICRORNA-211 (miR-211) IN THE BRAIN

miR-3132 upregulation of the TRAIL pathway and apoptotic activity in cancer cells

IMMUNOTHERAPEUTIC CONSTRUCTS AND METHODS OF THEIR USE

Diagnosis and treatment of psoriatic arthritis

Methods and compositions for managing vascular conditions using miR-483 mimics and HIF1alpha pathway inhibitors

5-halouracil-modified microRNAs and their use in the treatment of cancer

Method of treating fatty liver disease

Transposon-based transfection system for primary cells

METHODS OF MAKING TARGETED VESICLES, AND COMPOSITIONS MADE THEREBY

Method of Diagnosing Gastric Cancers Using MicroRNAs

MODULATING PTPN2 TO INCREASE IMMUNE RESPONSES AND PERTURBING GENE EXPRESSION IN HEMATOPOIETIC STEM CELL LINEAGES

CARDIOSPHERE-DERIVED CELLS AND EXOSOMES SECRETED BY SUCH CELLS IN THE TREATMENT OF MUSCULAR DYSTROPHY

RECOMBINANT VIRUS PRODUCTS AND METHODS FOR INHIBITION OF EXPRESSION OF MYOTILIN

T cells with improved functionality

USE OF miRNA IN PREPARATION OF A DRUG FOR PREVENTING AND TREATING OSTEOARTHRITIS, AN EXOSOME HIGHLY EXPRESSING miRNA AND USE THEREOF

Compositions and methods to treating hemoglobinopathies

Treatment of tumors with miRNA targeting CDK4/CDK6

REGULATION OF NUCLEOTIDE EXCISION REPAIR (NER) BY MICRORNA FOR TREATMENT OF CANCER

Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof

RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (SINA)

Gene therapy for retinitis pigmentosa

MIRNA FOR USE IN THERAPY

RNA nanoparticles and method of use thereof

ANELLOSOMES AND METHODS OF USE

Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)

MODULATION OF SPTLC1 VIA RECOMBINANT ADENO-ASSOCIATED VECTORS

Expression of miRNAs in Placental Tissue

Compositions and methods for treatment of cardiac diseases

USE OF miRNA 148 CLUSTER AS MARKER FOR DIAGNOSING AND/OR TREATING COGNITIVE IMPAIRMENT-ASSOCIATED DISEASES

SYSTEMIC IN VIVO DELIVERY OF OLIGONUCLEOTIDES

COMBINATION THERAPY FOR TREATING MUSCULAR DYSTROPHY

INDUCIBLE EXPRESSION OF GENES IN ALGAE

INHIBITORS OF CACNA1A/ALPHA1A SUBUNIT INTERNAL RIBOSOMAL ENTRY SITE (IRES) AND METHODS OF TREATING SPINOCEREBELLAR ATAXIA TYPE 6

System for producing cultivated meats, tissues and associated products from cells

ENGINEERED IMMUNOSTIMULATORY BACTERIAL STRAINS AND USES THEREOF

Intron fragments

RNAI INDUCED REDUCTION OF ATAXIN-3 FOR THE TREATMENT OF SPINOCEREBELLAR ATAXIA TYPE 3

AAV treatment of Huntington's disease

Acute kidney injury-specific biomarker, acute kidney injury diagnosis method, acute kidney injury test kit, animal treatment method and acute kidney injury medication

METHODS AND COMPOSITIONS FOR TRANSDUCING LYMPHOCYTES AND REGULATING THE ACTIVITY THEREOF

ARC-BASED CAPSIDS AND USES THEREOF

SYNTHETIC OLIGONUCLEOTIDES HAVING REGIONS OF BLOCK AND CLUSTER MODIFICATIONS

TRANS-ACTIVATED FUNCTIONAL RNA BY STRAND DISPLACEMENT AND USES THEREOF

Inhibition of expansion and function of pathogenic age-associated B cells and use for the prevention and treatment of autoimmune disease

METHOD FOR PRODUCING INDUCED PLURIPOTENT STEM CELLS USING RNA NANOPARTICLES FOR CELL TRANSFORMATION

Phosphorothioate-conjugated miRNAs and methods of using the same

Anti-angiogenic miRNA therapeutics for inhibiting corneal neovascularization

TARGET VALIDATION AND PROFILING OF THE RNA TARGETS OF SMALL MOLECULES

METHOD AND MEANS TO DELIVER miRNA TO TARGET CELLS

COMPOSITIONS AND METHODS FOR DELIVERY OF AAV

Nucleoside derivative and use thereof

Biodegradable lipids for delivery of nucleic acids

METHODS OF TREATING MOTOR NEURON DISEASES

DOUBLE-STRANDED OLIGO RNA STRUCTURE COMPRISING miRNA

Compositions and therapeutic methods of microRNA gene delivery

RNAi nano-preparation, preparation method thereof and application thereof in TMV prevention and control

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING MIR-324 and TUT4/7 EXPRESSION MODULATORS

The Microbiome as a Target of MicroRNAs for the Treatment of Disease

Modified AAV constructs and uses thereof

Compositions and methods for prevention of bladder fibrosis

Methods for treating subjects suffering from acute myeloid leukemia with FLT3 ligand-targeted miR-150 nanoparticles

THERAPEUTIC EXOSOMES AND METHOD OF PRODUCING THEM

Highly stable and specific molecular beacons encapsulated in cationic lipoplex nanoparticles and application thereof

GENE THERAPIES FOR LYSOSOMAL DISORDERS

Plant regulatory elements and uses thereof

Compositions and methods to restore paternal UBE3A gene expression in human Angelman syndrome

RNAI INDUCED C9ORF72 SUPPRESSION FOR THE TREATMENT OF ALS/FTD

HIV pre-immunization and immunotherapy

COMPOSITIONS AND METHODS FOR SEQUESTERING VIRUSES

AAV VECTORS FOR TREATMENT OF DOMINANT RETINITIS PIGMENTOSA

Compositions and methods for treating endometriosis

METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING T CELL-DRIVEN DISEASES

Heterologous targeting peptide grafted AAVs

RECOMBINANT AAV VECTORS USEFUL FOR REDUCING IMMUNITY AGAINST TRANSGENE PRODUCTS

Compositions and methods for modulating neuronal excitability and motor behavior

GENE TARGETS FOR T-CELL-BASED IMMUNOTHERAPY

MiRNA molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation

Nitrogen responsive transcription factors in plants

AGENT USING HSP47 INHIBITOR TO SUPPRESS METASTASIS

STABLE TARGETED INTEGRATION

Compositions of Asymmetric Interfering RNA and Uses Thereof

METHODS OF TREATING OSMIDROSIS

Selective inhibition of T Follicular Helper cells for treatment of autoimmune disorders

CO-DELIVERY OF NUCLEIC ACIDS FOR SIMULTANEOUS SUPPRESSION AND EXPRESSION OF TARGET GENES

COMPOSITIONS COMPRISING INTERMEDIATE NON-CODING RNA REGULATORS MODULATING THE EXPRESSION OF ETV6 OR FOXO1 AND USES THEREOF

LUNG CANCER DIAGNOSTICS AND THERAPEUTICS WITH MIR-660

Exosomes and miRNA to treat glaucoma

METHODS AND COMPOSITIONS FOR MODULATING CELLULAR AGING

METHODS OF SUPPRESSING DELIVERY OF EXOSOMES TO LIVER AND SPLEEN

Application of microRNA-210 inhibitor in preparation of drugs for treating inflammatory skin diseases

Compositions for Transfecting Resistant Cell Types

Engineered Exosomes for Medical Applications

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ACUTE AND CHRONIC PRURITIS

Targeting microRNA-101-3p in cancer therapy

Methods and compositions for sensitization of tumor cells to immune therapy

Short hairpin RNA compositions, methods of making and applications thereof

COMPOSITIONS AND METHODS FOR REDUCING SPLICEOPATHY AND TREATING RNA DOMINANCE DISORDERS

MULTIPLEXED SHRNAS AND USES THEREOF

MODIFICATION OF SMALL RNAS FOR THERAPEUTIC USES

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MUSCULAR DISEASE OR CACHEXIA COMPRISING, AS ACTIVE INGREDIENT, miRNA LOCATED IN DLK1-DIO3 CLUSTER OR VARIANT THEREOF

Matrix bound nanovesicles and their use

ANTIBODY-OLIGONUCLEOTIDE CONJUGATES

Methods for therapeutic administration of messenger ribonucleic acid drugs

Methods of genetic mediated engineering of RNAi models

METHOD FOR DETERMINING DECREASE IN FUNCTIONS OF HIPPOCAMPUS BY USING CORRELATION BETWEEN MICRO RNA AND NMDA RECEPTOR, METHOD FOR INHIBITING DECREASE IN FUNCTIONS, AND METHOD FOR SCREENING FOR INHIBITORS OF DECREASE IN FUNCTIONS

METHODS FOR TREATING SPINAL CORD INJURY

METHOD FOR TREATING CARDIOVASCULAR DISEASE

Structurally designed shRNAs

MIR-3132 UPREGULATION OF THE TRAIL PATHWAY AND APOPTOTIC ACTIVITY IN CANCER CELLS

Single-stranded oligonucleotide

INHIBITION OF CATALYTIC SITE COMMON TO MULTIPLE 3 ALPHA-OXIDOREDUCTASES FOR TREATMENT OF PROSTATE CANCER

METHODS OF TREATING DISORDERS

RAAV-based compositions and methods for treating amyotrophic lateral sclerosis

tRNA/pre-miRNA compositions and use in treating cancer

MIRI26-5P FOR TREATING MOTOR NEURON DISEASES

USING MICRORNAS TO CONTROL ACTIVATION STATUS OF HEPATIC STELLATE CELLS AND TO PREVENT FIBROSIS IN PROGRESSIVE LIVER DISEASES

Bioactive renal cells

MicroRNAs as therapeutic targets for ischemic stroke

Staufen1 regulating agents and associated methods

Compositions and kits for molecular counting

Synergistic genome-nonintegrating reprogramming by microRNAs and transcription factors

EXTRACELLULAR VESICLES LOADED WITH AN EXOGENOUS MOLECULE

Enhanced placental stem cells and uses thereof

AAV capsids identified by in vivo library selection

Self-attenuated prophylactic and therapeutic vaccines against pathogens

EDIBLE PLANT EXOSOME-LIKE NANOVECTORS FOR VACCINATION

Use of miR-132 and miR-212 in preparation of drug for treating addiction

Micro-RNAS and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions

Programmable conditional SIRNAS and uses thereof

COMPOSITIONS AND KITS FOR MOLECULAR COUNTING

NOVEL TARGET FOR ANTI-CANCER AND IMMUNE-ENHANCING

METHODS AND COMPOSITIONS TO STIMULATE RETINAL REGENERATION

COMPOSITIONS AND METHODS FOR INCREASING OR ENHANCING TRANSDUCTION OF GENE THERAPY VECTORS AND FOR REMOVING OR REDUCING IMMUNOGLOBULINS

Mesenchymal stem cell and use thereof for treatment of muscle injury and muscle-associated diseases

MODIFIED AAV CONSTRUCTS AND USES THEREOF

AMYGDALAR NEURAL ENSEMBLE THAT ENCODES THE UNPLEASANTNESS OF PAIN

Methods for treating cancers

Peptide docking vehicle for targeted nucleic acid delivery

REPEAT RNA AS BIOMARKERS OF TUMOR IMMUNE RESPONSE

Methods of enhancing immunity

Methods and compositions for inhibiting detoxification response

METHODS OF ACTIVATING CELLS VIA PTP 1B INHIBITION

Isolation of novel AAV's and uses thereof

Senile dementia treatment formulation and application thereof

METHODS FOR DETERMINING THE PRESENCE OR RISK OF DEVELOPING FACIOSCAPULOHUMERAL DYSTROPHY (FSHD)

Compositions and methods for treating eye disorders

AAV vectors for retinal and CNS gene therapy

Use of miR-223-3p as a cancer therapeutic and method for treating cancer using the same

Combination treatment for cystic fibrosis

METHODS OF MODULATING ANK1

ENHANCED REPROGRAMMING OF SOMATIC CELLS

CYTOBIOLOGICS AND THERAPEUTIC USES THEREOF

COMPOSITIONS AND USES THEREOF

Methods for production of MSC-derived exosomes

Transgene cassettes designed to express a human MECP2 gene

RECOMBINANT AAVS HAVING USEFUL TRANSCYTOSIS PROPERTIES

bZIP transcription factors regulate conversion of nicotine to nornicotine

TREATING HERPESVIRUS-MEDIATED INTESTINAL DYSFUNCTION FOR PREVENTION OF AGE-RELATED NEURODEGENERATION

Targeting Mirnas for Exosomal Delivery or Cellular Retention

COMPOSITIONS AND METHODS FOR INHIBITING THE PRODUCTION OR ACTIVITY OF D-2HYDROXYGLUTARATE IN SUBJECTS AFFLICTED WITH CANCER

CELLULAR COMPOSITIONS AND METHODS OF TREATMENT I

METHODS AND COMPOSITIONS FOR THE TREATMENT OF HEPATIC AND METABOLIC DISEASES

Targeting macula densa cells as a new therapeutic approach for kidney disease

COMPOSITIONS AND METHODS FOR MAKING ENGINEERED T CELLS

RNA-AIDED IMMUNOTHERAPEUTICS

Compositions and methods for disrupting the molecular mechanisms associated with mitochondrial dysfunction and neurodegenerative disease

Methods for treating NLRP3 inflammasome-associated diseases, and methods of identifying agents useful therefor

MiRNAs for treatment and in vitro diagnosis of drug resistant tumors

TRIPLE FUNCTION ADENO-ASSOCIATED VIRUS (AAV)VECTORS FOR THE TREATMENT OF C9ORF72 ASSOCIATED DISEASES

Use of trinucleotide repeat RNAs to treat cancer

PLANT SRNA EXTRACT FOR USE AS AN IMMUNOSUPPRESSIVE AGENT

Use of thermostable RNA polymerases to produce RNAs having reduced immunogenicity

Method for expanding stemness and differentiation potential of pluripotent cells